Seagen International GmbH is the base for international operations of Seagen Inc., a global biotechnology company that discovers, develops and commercializes transformative cancer medicines to make a meaningful difference in people’s lives. Seagen was acquired by Pfizer in 2023.
Products, services, technology
Seagen is a global biotechnology company that discovers, develops, and commercializes medicines for cancer. The company has a pipeline of therapies at various stages of preclinical testing, clinical testing, and development. For more information visit www.seagen.com.
- https://www.seagen.com/
- +41 58 257 23 01
- OfficeCH@seagen.com
